Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (2,222,663)	$ (2,480,250)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	1,677,835	1,786,268
Amortization of debt issuance costs	81,877	80,214
Stock based compensation expense related to issuance of restricted stock	3,900	2,835
Increase (decrease) in cash, cash equivalents, and restricted cash from changes in assets and liabilities:
Other assets	(81,162)	145,717
Accounts payable and accrued liabilities	251,350	426,549
Due to affiliates	805,290	432,759
Net cash provided by operating activities	516,427	394,092
Cash flows from investing activities:
Additions to real estate	(331,663)	(1,446,117)
Net cash used in investing activities	(331,663)	(1,446,117)
Cash flows from financing activities:
Principal payments of KeyBank Bridge Loans	(150,000)	(150,000)
Scheduled principal payments of mortgage loans	(435,073)	(428,845)
Debt issuance costs	(169,866)
Net cash used in financing activities	(754,939)	(578,845)
Net change in cash, cash equivalents, and restricted cash	(570,175)	(1,630,870)
Cash, cash equivalents, and restricted cash, beginning of period	8,288,459	12,544,609
Cash, cash equivalents, and restricted cash, end of period	7,718,284	10,913,739
Supplemental disclosures and non-cash transactions:
Cash paid for interest	2,252,820	2,203,447
Additions to real estate facilities and construction in process included in accounts payable and accrued liabilities		135,989
Debt issuance costs in accounts payable and accrued liabilities	48,736
Distributions payable to preferred unit holders in our Operating Partnership	$ 347,582	$ 322,853